The coronary stent market for Brazil, Russia, India, China, South Africa and South Korea (BRICSS) is estimated to reach $1.4 billion by 2015, according to a report by Research and Markets.
The firm expects the market to grow at a compound annual growth rate (CAGR) of 10.5% during the analysis period, 2009-2015 China accounts for nearly 30% of the market's global value, while India claims around 25%.
India and China are the fastest growing in terms of the CAGR, while South Korea and Russia are just behind.
Forecasts indicate that drug-eluting stents will account for nearly 65% of the market, while bare-metal stents will account nearly 25%.
In terms of technology, platinum-enriched stainless steel stents will have the largest CAGR, followed by antibody-coated and diamond carbon-coating, the report notes.